Adam S. Sperling, MD, PhD
Dr. Sperling received his medical degree and PhD in Biological Chemistry from the University of California, Los Angeles in 2011, where he worked on mechanisms of epigenetic gene regulation in the lab of Dr. Michael Grunstein. He completed his residency in internal medicine at the Brigham and Women’s Hospital and his fellowship in Hematology and Oncology at the Dana-Farber Cancer Institute. He is board certified in Internal Medicine, Medical Oncology, and Hematology. He completed his post-doctoral fellowship in the laboratory of Dr. Benjamin Ebert and is now an Assistant Professor of Medicine at Harvard Medical School and the Brigham and Women’s Hospital. His research focuses on understanding the mechanisms of disease evolution from pre-malignant conditions and the development of drug resistance in multiple myeloma and other hematologic malignancies. In the clinic he cares for patients with multiple myeloma, monoclonal gammopathies and clonal hematopoiesis.
Ravi K. Dutta, PhD
Dr. Dutta received his PhD from the Department of Biomedical and Clinical Sciences, Linköping University, Sweden. He joined the Sperling Lab in November of 2021. His research focuses on understanding the mechanism of thalidomide analog resistance in multiple myeloma.
Julian Partha Bhowmik, MD
Julian Partha Bhowmik is a physician from Germany who recently received his medical degree from the Eberhard Karls University Tuebingen, Germany. He did his experimental doctoral thesis in basic cardiovascular research at the Department of Cardiology and Angiology, at University Hospital of Tuebingen.
He joined the Sperling Lab in September 2022. Here, his research focuses on the epxression and mechanism of the regulation of key cell surface markers in hematological malignancies, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Anuja Paudyal, PhD
Anuja received her PhD from the Division of Biology at Kansas State University. She joined the Sperling Lab in January of 2023. Her research focuses on understanding the DNA damage response after drug treatment and during the development of clonal hematopoiesis and hematologic malignancies.
Jonah F Boardman, BS
Jonah graduated from Brown University with a B.S. in Biochemistry. He joined the Sperling lab in July of 2023. His research focuses on the regulation of cell surface markers in hematological malignancies.
Sisasenkosi Mandi, BSc
Sisa received her Bachelor of Science degree from Brown University, where she majored in Biology. She joined the Sperling Lab in July of 2022. Here, her research focuses on understanding hematological malignancies and mechanisms of resistance.
Vanessa A Quevedo Barrios, BA
Vanessa graduated from Williams College in 2021 where she majored in Chemistry and Arabic. She spent two years in the Sperling Lab as a research associate and is now pursuing a PhD at the University of Michigan.